| Literature DB >> 33088500 |
Yasue Kimura1, Hiroshi Saeki2, Qingjiang Hu1, Yuichi Hisamatsu1, Mioko Matsuo3, Sei Yoshida4, Eiji Oki1, Ryuji Yasumatsu3, Hideaki Kadota4, Masaki Mori1.
Abstract
BACKGROUND: Total pharyngolaryngoesophagectomy (TPLE) is associated with major complications and is extremely invasive. In 2011, our institution introduced thoracoscopic esophagectomy in the left hemi-prone position and laparoscopic reconstruction with a gastric tube in patients undergoing TPLE. Herein, we describe the use of this operative method in 26 patients, focusing on the technical aspects of the surgery.Entities:
Keywords: Esophageal cancer; Thoracoscopic esophagectomy; Total pharyngolaryngoesophagectomy (TPLE)
Year: 2020 PMID: 33088500 PMCID: PMC7567906 DOI: 10.1016/j.amsu.2020.10.006
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Operative schema.
(a) Reconstruction with a gastric tube after total esophagectomy.
In cases where venous microvascular anastomosis (super-drainage) was performed, the short gastric vein or posterior gastric vein was anastomosed to the anterior jugular vein or the internal or external jugular vein. Arterial anastomosis was sometimes added.
(b) Reconstruction with a gastric tube and jejunal flap after total esophagectomy.
Venous and arterial microvascular anastomosis was performed.
Clinicopathological features of the 26 patients who underwent thoracoscopic TPLE.
| Case | Age | Sex | HNC | UICC stage of HNC | Location of main tumor | UICC stage of esophageal cancer | Reconstruction | Microvascular anastomosis | Curability | Preoperative therapy | Complications | Pneumonia | Leakage |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 36 | M | None | Ce | 0 | Gastric tube | Vein | Curative | NAC | None | None | None | |
| 2 | 38 | M | Hypopharyngeal cancer | II | Ce | III | Gastric tube | None | Curative | NAC | Present | None | None |
| 3 | 50 | M | None | Ce | 0 | Gastric tube | Artery/vein | Curative | NAC | None | None | None | |
| 4 | 56 | M | None | Ce | III | Gastric tube + FJF | Artery/vein | Curative | NACRT | Present | None | Present | |
| 5 | 57 | M | None | Ce | II | Gastric tube | Vein | Curative | NACRT | None | None | None | |
| 6 | 59 | M | Laryngeal cancer | IVA | Mt | III | Gastric tube + FJF | Artery/vein | Curative | NACRT | None | None | None |
| 7 | 62 | M | None | Ce | II | Gastric tube | Vein | Non-curative | NAC | None | None | None | |
| 8 | 62 | M | Hypopharyngeal cancer | IVA | Mt | IVA | Gastric tube + FJF | Artery/vein | Curative | NAC | None | None | None |
| 9 | 63 | M | Hypopharyngeal cancer | IVA | Ut | IVA | Gastric tube | Vein | Curative | NAC | None | None | None |
| 10 | 64 | M | None | Ut | I | Gastric tube | Vein | Non-curative | NACRT | None | None | None | |
| 11 | 64 | M | Hypopharyngeal cancer | 0 | Ce | IVA | Gastric tube | Artery/vein | Curative | None | Present | None | None |
| 12 | 66 | F | None | Ce | II | Gastric tube + FJF | Artery/vein | Curative | NAC | None | None | None | |
| 13 | 66 | M | None | Ce | I | Gastric tube + FJF | Artery/vein | Curative | NAC | None | None | None | |
| 14 | 66 | M | None | Ce | III | Gastric tube + FJF | Artery/vein | Non-curative | dCRT | Present | None | None | |
| 15 | 67 | M | None | Ce | IVA | Gastric tube + FJF | Artery/vein | Curative | NAC | None | None | None | |
| 16 | 69 | M | Hypopharyngeal cancer | IVA | Mt | 0 | Gastric tube | Artery and vein | Curative | None | None | None | None |
| 17 | 71 | M | None | Ce | I | Gastric tube | None | Non-curative | NAC | None | None | None | |
| 18 | 73 | M | Hypopharyngeal cancer | IVA | Mt | III | Gastric tube + FJF | Artery/vein | Curative | None | None | None | None |
| 19 | 74 | M | None | Ce | III | Gastric tube | Vein | Curative | None | None | None | None | |
| 20 | 74 | M | None | Ce | I | Gastric tube | Vein | Curative | NACRT | None | None | None | |
| 21 | 74 | M | None | Ut | IVA | Gastric tube | Vein | Non-curative | NAC | Present | Present | None | |
| 22 | 75 | M | None | Ce | II | Gastric tube + FJF | Artery/vein | Non-curative | NAC | None | None | None | |
| 23 | 76 | M | None | Ce | II | Gastric tube | None | Curative | NAC | Present | None | Present | |
| 24 | 77 | M | None | Ce | III | Gastric tube + FJF | Artery/vein | Curative | NAC | Present | None | None | |
| 25 | 77 | M | Hypopharyngeal cancer | III | Ce | II | Gastric tube | Vein | Curative | NAC | Present | None | None |
| 26 | 80 | M | None | Ut | II | Gastric tube | Vein | Non-Curative | NACRT | Present | None | None |
TPLE: total pharyngolaryngoesophagectomy, HNC: head and neck cancer, FJF: free jejunal flap, NAC: neoadjuvant chemotherapy, NACRT: neoadjuvant chemoradiotherapy, dCRT: definitive chemoradiotherapy, UICC: Union for International Cancer Control.
Operative factors and complications of thoracoscopic total pharyngolaryngoesophagectomy (n = 26).
| Variable | Number (%) | Median (range) |
|---|---|---|
| Operation time (min) | 760 (561–885) | |
| Blood loss (ml) | 359(250-1527) | |
| ICU stay (days) | 1.7 (1–5) | |
| Anastomotic leakage | 2 (7.7) | |
| Pneumonia | 1 (3.8) | |
| Other complications | 3 (11.5) |